BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moore JC, Fu J, Chan YC, Lin D, Tran H, Tse HF, Li RA. Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem Biophys Res Commun. 2008;372:553-558. [PMID: 18503758 DOI: 10.1016/j.bbrc.2008.05.076] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Moore JC, Sadowy S, Alikani M, Toro-Ramos AJ, Swerdel MR, Hart RP, Cohen RI. A high-resolution molecular-based panel of assays for identification and characterization of human embryonic stem cell lines. Stem Cell Res 2010;4:92-106. [PMID: 20060795 DOI: 10.1016/j.scr.2009.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
2 Chow M, Boheler KR, Li RA. Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives. Stem Cell Res Ther 2013;4:97. [PMID: 23953772 DOI: 10.1186/scrt308] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sun Y, Timofeyev V, Dennis A, Bektik E, Wan X, Laurita KR, Deschênes I, Li RA, Fu JD. A Singular Role of IK1 Promoting the Development of Cardiac Automaticity during Cardiomyocyte Differentiation by IK1 -Induced Activation of Pacemaker Current. Stem Cell Rev Rep 2017;13:631-43. [PMID: 28623610 DOI: 10.1007/s12015-017-9745-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
4 Ma J, Guo L, Fiene SJ, Anson BD, Thomson JA, Kamp TJ, Kolaja KL, Swanson BJ, January CT. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol. 2011;301:H2006-H2017. [PMID: 21890694 DOI: 10.1152/ajpheart.00694.2011] [Cited by in Crossref: 482] [Cited by in F6Publishing: 416] [Article Influence: 48.2] [Reference Citation Analysis]
5 Cutts J, Nikkhah M, Brafman DA. Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering. Biomark Insights 2015;10:77-90. [PMID: 26052226 DOI: 10.4137/BMI.S20313] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
6 Xi L, Zhu SG, Das A, Chen Q, Durrant D, Hobbs DC, Lesnefsky EJ, Kukreja RC. Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications. Nitric Oxide 2012;26:274-84. [PMID: 22484629 DOI: 10.1016/j.niox.2012.03.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
7 Nelson BC, Hashem SI, Adler ED. Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders. Curr Cardiol Rep 2017;19:26. [PMID: 28251514 DOI: 10.1007/s11886-017-0829-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Weng Z, Kong CW, Ren L, Karakikes I, Geng L, He J, Chow MZ, Mok CF, Chan HYS, Webb SE, Keung W, Chow H, Miller AL, Leung AY, Hajjar RJ, Li RA, Chan CW. A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells. Stem Cells Dev 2014;23:1704-16. [PMID: 24564569 DOI: 10.1089/scd.2013.0509] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 11.3] [Reference Citation Analysis]
9 Fu JD, Jiang P, Rushing S, Liu J, Chiamvimonvat N, Li RA. Na+/Ca2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes. Stem Cells Dev 2010;19:773-82. [PMID: 19719399 DOI: 10.1089/scd.2009.0184] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
10 Gupta MK, Illich DJ, Gaarz A, Matzkies M, Nguemo F, Pfannkuche K, Liang H, Classen S, Reppel M, Schultze JL, Hescheler J, Sarić T. Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol 2010;10:98. [PMID: 20843318 DOI: 10.1186/1471-213X-10-98] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 5.2] [Reference Citation Analysis]
11 Zhu WZ, Xie Y, Moyes KW, Gold JD, Askari B, Laflamme MA. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ Res 2010;107:776-86. [PMID: 20671236 DOI: 10.1161/CIRCRESAHA.110.223917] [Cited by in Crossref: 165] [Cited by in F6Publishing: 94] [Article Influence: 15.0] [Reference Citation Analysis]
12 Hartman ME, Dai DF, Laflamme MA. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev 2016;96:3-17. [PMID: 25980938 DOI: 10.1016/j.addr.2015.05.004] [Cited by in Crossref: 86] [Cited by in F6Publishing: 64] [Article Influence: 14.3] [Reference Citation Analysis]
13 Geng L, Kong CW, Wong AOT, Shum AM, Chow MZY, Che H, Zhang C, Yau KL, Chan CW, Keung W, Li RA. Probing flecainide block of INa using human pluripotent stem cell-derived ventricular cardiomyocytes adapted to automated patch-clamping and 2D monolayers. Toxicol Lett. 2018;294:61-72. [PMID: 29758359 DOI: 10.1016/j.toxlet.2018.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kharaziha M, Memic A, Akbari M, Brafman DA, Nikkhah M. Nano-Enabled Approaches for Stem Cell-Based Cardiac Tissue Engineering. Adv Healthc Mater 2016;5:1533-53. [PMID: 27199266 DOI: 10.1002/adhm.201600088] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
15 Wang J, Chen A, Lieu DK, Karakikes I, Chen G, Keung W, Chan CW, Hajjar RJ, Costa KD, Khine M, Li RA. Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias. Biomaterials 2013;34:8878-86. [PMID: 23942210 DOI: 10.1016/j.biomaterials.2013.07.039] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
16 Xu H, Yi BA, Wu H, Bock C, Gu H, Lui KO, Park JH, Shao Y, Riley AK, Domian IJ, Hu E, Willette R, Lepore J, Meissner A, Wang Z, Chien KR. Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Res 2012;22:142-54. [PMID: 22064699 DOI: 10.1038/cr.2011.171] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
17 Boheler KR, Poon EN. Cell surface markers for immunophenotyping human pluripotent stem cell-derived cardiomyocytes. Pflugers Arch 2021;473:1023-39. [PMID: 33928456 DOI: 10.1007/s00424-021-02549-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wang K, Terrenoire C, Sampson KJ, Iyer V, Osteen JD, Lu J, Keller G, Kotton DN, Kass RS. Biophysical properties of slow potassium channels in human embryonic stem cell derived cardiomyocytes implicate subunit stoichiometry. J Physiol 2011;589:6093-104. [PMID: 22025662 DOI: 10.1113/jphysiol.2011.220863] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
19 Hattori F, Fukuda K. Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium. Exp Mol Med. 2010;42:155-165. [PMID: 20164677 DOI: 10.1016/j.trre.2011.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
20 Li S, Chen G, Li RA. Calcium signalling of human pluripotent stem cell-derived cardiomyocytes. J Physiol. 2013;591:5279-5290. [PMID: 24018947 DOI: 10.1113/jphysiol.2013.256495] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
21 Zambon AC, Barker CS. Microarray Analysis of Embryonic Stem Cells and Differentiated Embryoid Bodies. In: Chittur SV, editor. Microarray Methods for Drug Discovery. Totowa: Humana Press; 2010. pp. 45-61. [DOI: 10.1007/978-1-60761-663-4_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Chow MZ, Geng L, Kong CW, Keung W, Fung JC, Boheler KR, Li RA. Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth. Stem Cells Dev 2013;22:2678-90. [PMID: 23656529 DOI: 10.1089/scd.2013.0125] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
23 Wobus AM, Löser P. Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol 2011;85:79-117. [PMID: 21225242 DOI: 10.1007/s00204-010-0641-6] [Cited by in Crossref: 105] [Cited by in F6Publishing: 72] [Article Influence: 10.5] [Reference Citation Analysis]
24 Talkhabi M, Aghdami N, Baharvand H. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art. Life Sci. 2016;145:98-113. [PMID: 26682938 DOI: 10.1016/j.lfs.2015.12.023] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
25 Poon E, Kong CW, Li RA. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Mol Pharm 2011;8:1495-504. [PMID: 21879736 DOI: 10.1021/mp2002363] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
26 Liu J, Laksman Z, Backx PH. The electrophysiological development of cardiomyocytes. Adv Drug Deliv Rev 2016;96:253-73. [PMID: 26788696 DOI: 10.1016/j.addr.2015.12.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
27 Robertson C, Tran DD, George SC. Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells. 2013;31:829-837. [PMID: 23355363 DOI: 10.1002/stem.1331] [Cited by in Crossref: 222] [Cited by in F6Publishing: 192] [Article Influence: 31.7] [Reference Citation Analysis]
28 Fu JD, Rushing SN, Lieu DK, Chan CW, Kong CW, Geng L, Wilson KD, Chiamvimonvat N, Boheler KR, Wu JC. Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One. 2011;6:e27417. [PMID: 22110643 DOI: 10.1371/journal.pone.0027417] [Cited by in Crossref: 123] [Cited by in F6Publishing: 112] [Article Influence: 12.3] [Reference Citation Analysis]
29 Atmanli A, Domian IJ. Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease. Trends Cell Biol 2017;27:352-64. [PMID: 28007424 DOI: 10.1016/j.tcb.2016.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
30 Ng KM, Chan YC, Lee YK, Lai WH, Au KW, Fung ML, Siu CW, Li RA, Tse HF. Cobalt chloride pretreatment promotes cardiac differentiation of human embryonic stem cells under atmospheric oxygen level. Cell Reprogram. 2011;13:527-537. [PMID: 22029419 DOI: 10.1089/cell.2011.0038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
31 Liew LC, Ho BX, Soh BS. Mending a broken heart: current strategies and limitations of cell-based therapy. Stem Cell Res Ther 2020;11:138. [PMID: 32216837 DOI: 10.1186/s13287-020-01648-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
32 Denning C, Anderson D. Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity. Drug Discovery Today: Therapeutic Strategies 2008;5:223-32. [DOI: 10.1016/j.ddstr.2008.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
33 Mehta A, Chung YY, Ng A, Iskandar F, Atan S, Wei H, Dusting G, Sun W, Wong P, Shim W. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovascular Research 2011;91:577-86. [DOI: 10.1093/cvr/cvr132] [Cited by in Crossref: 77] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
34 Li Y, Li B, Zhang C, Zhang J, Zeng M, Zheng Z. Effect of NRG-1/ErbB signaling intervention on the differentiation of bone marrow stromal cells into sinus node-like cells. J Cardiovasc Pharmacol 2014;63:434-40. [PMID: 24390172 DOI: 10.1097/FJC.0000000000000068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
35 Yu JK, Franceschi W, Huang Q, Pashakhanloo F, Boyle PM, Trayanova NA. A comprehensive, multiscale framework for evaluation of arrhythmias arising from cell therapy in the whole post-myocardial infarcted heart. Sci Rep 2019;9:9238. [PMID: 31239508 DOI: 10.1038/s41598-019-45684-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
36 Gundry RL, Burridge PW, Boheler KR. Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology. Proteomics 2011;11:3947-61. [PMID: 21834136 DOI: 10.1002/pmic.201100100] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
37 Chang KH, Nelson AM, Fields PA, Hesson JL, Ulyanova T, Cao H, Nakamoto B, Ware CB, Papayannopoulou T. Diverse hematopoietic potentials of five human embryonic stem cell lines. Exp Cell Res. 2008;314:2930-2940. [PMID: 18692044 DOI: 10.1016/j.yexcr.2008.07.019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
38 Xu C, Police S, Hassanipour M, Li Y, Chen Y, Priest C, O’Sullivan C, Laflamme MA, Zhu WZ, Van Biber B. Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regen Med. 2011;6:53-66. [PMID: 21175287 DOI: 10.2217/rme.10.91] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
39 Li RA. Gene- and cell-based bio-artificial pacemaker: what basic and translational lessons have we learned? Gene Ther 2012;19:588-95. [PMID: 22673497 DOI: 10.1038/gt.2012.33] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
40 Hattori F, Fukuda K. Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium. Exp Mol Med 2010;42:155-65. [PMID: 20164677 DOI: 10.3858/emm.2010.42.3.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
41 Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104:e30-e41. [PMID: 19213953 DOI: 10.1161/circresaha.108.192237] [Cited by in Crossref: 882] [Cited by in F6Publishing: 509] [Article Influence: 73.5] [Reference Citation Analysis]
42 Zhu R, Millrod MA, Zambidis ET, Tung L. Variability of Action Potentials Within and Among Cardiac Cell Clusters Derived from Human Embryonic Stem Cells. Sci Rep 2016;6:18544. [PMID: 26729331 DOI: 10.1038/srep18544] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
43 Blazeski A, Zhu R, Hunter DW, Weinberg SH, Boheler KR, Zambidis ET, Tung L. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog Biophys Mol Biol. 2012;110:178-195. [PMID: 22958937 DOI: 10.1016/j.pbiomolbio.2012.07.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
44 Keung W, Boheler KR, Li RA. Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 2014;5:17. [PMID: 24467782 DOI: 10.1186/scrt406] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 8.4] [Reference Citation Analysis]
45 Xi L, Zhu SG, Hobbs DC, Kukreja RC. Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity. J Cell Mol Med 2011;15:2512-24. [PMID: 21251210 DOI: 10.1111/j.1582-4934.2011.01257.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
46 Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One. 2011;6:e18293. [PMID: 21494607 DOI: 10.1371/journal.pone.0018293] [Cited by in Crossref: 286] [Cited by in F6Publishing: 253] [Article Influence: 28.6] [Reference Citation Analysis]
47 Karakikes I, Senyei GD, Hansen J, Kong CW, Azeloglu EU, Stillitano F, Lieu DK, Wang J, Ren L, Hulot JS. Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. Stem Cells Transl Med. 2014;3:18-31. [PMID: 24324277 DOI: 10.5966/sctm.2013-0110] [Cited by in Crossref: 100] [Cited by in F6Publishing: 81] [Article Influence: 12.5] [Reference Citation Analysis]
48 Lee MY, Sun B, Schliffke S, Yue Z, Ye M, Paavola J, Bozkulak EC, Amos PJ, Ren Y, Ju R, Jung YW, Ge X, Yue L, Ehrlich BE, Qyang Y. Derivation of functional ventricular cardiomyocytes using endogenous promoter sequence from murine embryonic stem cells. Stem Cell Res 2012;8:49-57. [PMID: 22099020 DOI: 10.1016/j.scr.2011.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
49 Lieu DK, Fu JD, Chiamvimonvat N, Tung KC, McNerney GP, Huser T, Keller G, Kong CW, Li RA. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol. 2013;6:191-201. [PMID: 23392582 DOI: 10.1161/circep.111.973420] [Cited by in Crossref: 130] [Cited by in F6Publishing: 96] [Article Influence: 16.3] [Reference Citation Analysis]
50 Ting S, Lecina M, Chan YC, Tse HF, Reuveny S, Oh SK. Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells 2013;5:86-97. [PMID: 23904910 DOI: 10.4252/wjsc.v5.i3.86] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
51 Sepac A, Si-Tayeb K, Sedlic F, Barrett S, Canfield S, Duncan SA, Bosnjak ZJ, Lough JW. Comparison of cardiomyogenic potential among human ESC and iPSC lines. Cell Transplant 2012;21:2523-30. [PMID: 22863088 DOI: 10.3727/096368912X653165] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
52 Pekkanen-Mattila M, Ojala M, Kerkelä E, Rajala K, Skottman H, Aalto-Setälä K. The effect of human and mouse fibroblast feeder cells on cardiac differentiation of human pluripotent stem cells. Stem Cells Int 2012;2012:875059. [PMID: 22315618 DOI: 10.1155/2012/875059] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
53 Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A. Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol. 2008;45:523-529. [PMID: 18835562 DOI: 10.1016/j.yjmcc.2008.09.122] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
54 Gorospe G, Zhu R, Millrod MA, Zambidis ET, Tung L, Vidal R. Automated grouping of action potentials of human embryonic stem cell-derived cardiomyocytes. IEEE Trans Biomed Eng 2014;61:2389-95. [PMID: 25148658 DOI: 10.1109/TBME.2014.2311387] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
55 Mehta A, Mathew S, Viswanathan C, Majumdar SA. Intrinsic properties and external factors determine the differentiation bias of human embryonic stem cell lines. Cell Biology International 2010;34:1021-31. [DOI: 10.1042/cbi20100283] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]